Results for "Inexpensive medicines https://simplemedrx.top"
HDA Convenes Supply Chain Experts and Patient Advocates To Examine Drug Shortages Solutions
HDA recently hosted a LinkedIn Live discussion exploring how supply chain stakeholders are working together to tackle these challenges and advocate for solutions. The event featured perspectives from Laura Bray, Chief Change Maker and Founder of Angels for Change, and April Giles, Executive Director of the End Drug Shortages Alliance (EDSA). Chip Davis, HDA President and Chief Executive Officer, moderated the discussion, which also touched upon effects of recent hurricanes on the prescription supply and the newly announced Biden Cancer Moonshot pilot program to curb pediatric shortages.
Read three takeaways from the conversation.
HDA Research Foundation Announces 2022–2023 Karen J. Ribler Supply Chain Scholars
The HDA Research Foundation today announced the four recipients of its graduate-level Karen J. Ribler Scholarship.
HDA Research Foundation Announces the 2023 Karen J. Ribler Supply Chain Scholars
The HDA Research Foundation announced four recipients of the Karen J. Ribler Scholarship at its Fifteenth Annual CEO Roundtable Fundraiser in Washington, D.C.
HDA Research Foundation Names Apotex and Anda Executives To Lead Board of Directors
The HDA Research Foundation announced Steve Giuli of Apotex Corp. as Chairman of its Board of Directors. Anthony Mihelich of Anda, Inc., was named Vice Chairman.
HDA’s Davis Shares 2022 Strategic Priorities Under Increased Awareness of Supply Chains
Events spanning COVID-19 vaccine distribution to shipping containers held up at port have made the supply chain a “kitchen-table” issue during the past year. Many industries experienced notable disruptions in their delivery of goods and supplies; however, as noted by President and CEO Chip Davis, “[P]harmacies, health systems and physicians’ offices, more than 180,000 across the country, remain stocked with the lifesaving medications and vaccines patients need. That didn’t happen by accident.” Davis’ perspective was featured alongside healthcare supply chain association leaders as part of Chain Drug Review’s annual “Pharmacy Outlook” feature.